Altered expression of neuronal nitric oxide synthase in weaver mutant mice

Brain Research

Volumn 1326, Issue , 2010, Pages 40-50

  Cavalcanti Kwiatkoski, Roberta ^a   Raisman Vozari, Rita ^b   Ginestet, Laure ^b   Del Bel, Elaine ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE   (France)

Author keywords

Brain; Nitric oxide synthase; Parkinson; Weaver mutant

Indexed keywords

DOPAMINE; NEURONAL NITRIC OXIDE SYNTHASE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS; VENTRAL TEGMENTUM;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; BRAIN; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNELS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENOTYPE; MICE; MICE, NEUROLOGIC MUTANTS; NITRIC OXIDE SYNTHASE TYPE I; TYROSINE 3-MONOOXYGENASE;

ANIMALIA; MUS;

EID: 77950297896     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.02.056     Document Type: Article

References (90)

1. Adelbrecht C., Agid Y., and Raisman-Vozari R. Effect of the weaver mutation on the expression of dopamine transporter, tyrosine hydroxylase and vesicular monoamine transporter in dopaminergic neurons of the substantia nigra and the ventral tegmental area. Brain Res. Mol. Brain Res. 43 1-2 (1996) 291-300
2. Albin R.L., Young A.B., and Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci. 12 10 (1989) 366-375
3. Araki T., Matsubara M., Fujihara K., Kato H., Imai Y., and Itoyama Y. GABA and benzodiazepine receptor alterations in the rat brain after unilateral 6-hydroxydopamine lesions of the medial forebrain bundle. Neurol. Res. 24 1 (2002) 107-112
4. Barthwal M.K., Srivastava N., and Dikshit M. Role of nitric oxide in a progressive neurodegeneration model of Parkinson's disease in the rat. Redox Rep. 6 (2001) 297-302
5. Bayer S.A., Triarhou L.C., Thomas J.D., and Ghetti B. Correlated quantitative studies of the neostriatum, nucleus accumbens, substantia nigra, and ventral tegmental area in normal and weaver mutant mice. J Neurosc 14 (1994) 6901-6910
6. Bezard E., Boraud T., Bioulac B., and Gross C.E. Involvement of the subthalamic nucleus in glutamatergic compensatory mechanisms. Eur. J. Neurosci. 11 6 (1999) 2167-2170
7. Canals S., Casarejos M.J., de Bernardo S., Rodríguez-Martín E., and Mena M. Glutathione depletion switches nitric oxide neurotrophic effects to cell death in midbrain cultures: implication for Parkinson's diease. J. Neurochem. 79 6 (2001) 1183-1195
8. Ceccatelli S., and Eriksson M. The effect of lactation on nitric oxide synthase gene expression. Brain Res. 625 1 (1993) 177-179
9. Chalimoniuk M., and Langfort J. The effect of subchronic, intermittent L-DOPA treatment on neuronal NOS and soluble GC expression and activity in the striatum and midbrain of normal and MPTP-treated mice. Neurochem. Int. 50 (2007) 821-833
10. Chase T.N., Bibbiani F., and Oh J.D. Striatal glutamatergic mechanisms and extrapyramidal movement disorders. Neurotox. Res. 5 1-2 (2003) 139-146
11. Cragg S.J., Baufreton J., Xue Y., Bolam J.P., and Bevam M.D. Synaptic release of dopamine in the subthalamic nucleus. Eur. J. Neurosci. 20 (2004) 1788-1802
12. Dauer W., and Przedborski S. Parkinson's disease: mechanisms and models. Neuron 39 (2003) 889-909
13. Del Bel E.A., Guimaraes F.S., Bermudez-Echeverry M., Gomes M.Z., Schiaveto-de-Souza A., Padovan-Neto F.E., Tumas V., Barion-Cavalcanti A.P., Lazzarini M., Nucci-da-Silva L.P., and de Paula-Souza D. Role of NO on motor behavior. Cell. Mol. Neurobiol. 25 (2005) 371-392
14. Di Giovanni G., Ferraro G., Sardo P., Galati S., Esposito E., and La Grutta V. Nitric oxide modulates striatal neuronal activity via soluble guanylyl cyclase: an in vivo microiontophoretic study in rats. Synapse 48 2 (2003) 100-107
15. Douhou A., Debeir T., Michel P.P., Stankovski L., Oueghlani-Bouslama L., Verney C., and Raisman-Vozari R. Differential activation of astrocytes and microglia during post-natal development of dopaminergic neuronal death in the weaver mouse. Brain Res. Dev. Brain Res. 145 1 (2003) 9-17
16. Franklin, and Paxinos G. The Mouse Brain in Stereotaxic Coordinates (1997), Academic Press, New York
17. Garthwaite J. Concepts of neural nitric oxide-mediated transmission. Eur. J. Neurosci. 27 (2008) 2783-2802
18. Gatto E.M., Riobó N., Carreras M.C., Poderoso J.J., and Micheli F.E. Neuroprotection in Parkinson's disease; a commentary. Neurotox. Res. 4 2 (2002) 141-145
19. Ginestet L., Ferrario J.E., Raisman-Vozari R., Hirsch E.C., and Debeir T. Donepezil induces a cholinergic sprouting in basocortical degeneration. J. Neurochem. 102 2 (2007) 434-440
20. Goldowitz D. The weaver granuloprival phenotype is due to intrinsic action of the mutant locus in granule cells: evidence from homozygous weaver chimeras. Neuron 2 6 (1989) 1565-1575
21. Goldstein J.A., and Blaisdell J. Genetic tests which identify the principal defects in CYP2C19 responsible for the polymorphism in mephenytoin metabolism. Methods Enzymol. 272 (1996) 210-218
22. Gomes M.Z., Raisman-Vozari R., and Del Bel E.A. A nitric oxide synthase inhibitor decreases 6-hydroxydopamine effects on tyrosine hydroxylase and neuronal nitric oxide synthase in the rat nigrostriatal pathway. Brain Res. 1203 (2008) 160-169
23. González-Hernández T., Barroso-Chinea P., and Rodríguez M. Response of the GABAergic and DAergic mesostriatal projections to the lesion of the contralateral dopaminergic mesostriatal pathway in the rat. Mov. Disord. 19 9 (2004) 1029-1042
24. Graybiel A.M., Ohta K., and Roffler-Tarlov S. Patterns of cell and fiber vulnerability in the mesostriatal system of the mutant mouse weaver. I - Gradients and compartments. J. Neurosci. 10 (1990) 720-733
25. Gupta M., Felten D.L., and Ghetti B. Selective loss of monoaminergic neurons in weaver mutant mice an immunocytochemical study. Brain Res. 402 379 (1987) 382
26. Hara M.R., and Snyder S.H. Cell signaling and neuronal death. Annu. Rev. Pharmacol. Toxicol. 47 (2007) 117-141
27. Hassani K., François C., Yelnik J., and Féger J. Evidence for a dopaminergic innervation of the subthalamic nucleus in the rat. Brain Res. 749 (1997) 88-94
28. Herbison A.E., Simonian S.X., Norris P.J., and Emson P.C. Relationship of neuronal nitric oxide synthase immunoreactivity to GnRH neurons in the ovariectomized and intact female rat. J. Neuroendocrinol. 8 (1996) 73-82
29. Hess E.J. Identification of the weaver mouse mutation: the end of the beginning. Neuron 16 6 (1996) 1073-1076
30. Hess D.T., Matsumoto A., Kim S.O., Marshall H.E., and Stamler J.S. Protein S-nitrosylation: purview and parameters. Nat. Rev. Mol. Cell Biol. 6 (2005) 150-155
31. Hirsch E.C., Périer C., Orieux G., François C., Féger J., Yelnik J., Vila M., Levy R., Tolosa E.S., Marin C., Herrero M.T., Obeso J.A., and Agid Y. Metabolic effects of nigrostriatal denervation in basal ganglia. Trends Neurosci. 23 (2000) S78-S85
32. Hopper R.A., and Garthwaite J. Tonic and phasic nitric oxide signal in hippocampal long-term potentiation. J. Neurosci. 8 26(45) (2006) 11513-11521
33. Hunot S., Boissière F., Faucheux B., Brugg B., Mouatt-Prigent A., Agid Y., and Hirsch E.C. Nitric oxide synthase and neuronal vulnerability in Parkinson's disease. Neuroscience 72 2 (1996) 355-363
34. Inanobe A., Yoshimoto Y., Horio Y., Morishige K.I., Hibino H., Matsumoto S., Tokunaga Y., Maeda T., Hata Y., Takai Y., and Kurachi Y. Characterization of G-protein-gated K+ channels composed of Kir3.2 subunits in dopaminergic neurons of the substantia nigra. J. Neurosci. 19 3 (1999) 1006-1017
35. Ishida A., Trescher W.H., Lange M.S., and Johnston M.V. Prolonged suppression of brain nitric oxide synthase activity by 7-nitroindazole protects against cerebral hypoxic-ischemic injury in neonatal rat. Brain Dev. 23 (2001) 349-354
36. Jackson-Lewis V., and Smeyne R.J. MPTP and SNpc DA neuronal vulnerability: role of dopamine, superoxide and nitric oxide in neurotoxicity. Neurotox. Res. 7 3 (2005) 193-202
37. Jenner P. Molecular mechanisms of L-DOPA-induced dyskinesia. Nat. Rev. Neurosci. 9 (2008) 665-677
38. Kawaguchi Y., Wilson C.J., Augood S.J., and Emson P.C. Striatal interneurones: chemical, physiological and morphological characterization. Trends Neurosci. 18 (1995) 527-535
39. Kofuji P., Hofer M., Millen K.J., Milloning J.H., Davidson N., Lester H.A., and Hatten M.E. Functional analysis of the weaver mutant GIRK2 K+ channel and rescue of weaver granule cells. Neuron 16 5 (1996) 941-952
40. Lalonde R., and Strazielle C. Brain regions and genes affcting postural control. Prog. Neurobiol. 81 1 (2007) 45-60
41. Lane E., and Dunnett S. Animal models of Parkinson's disease and L-dopa induced dyskinesia: how close are we to the clinic?. Psychopharmacology 199 (2008) 303-312
42. Lipton S.A., Choi Y.B., Pan Z.H., Lei S.Z., Chen H.S., Sucher N.J., Loscalzo J., Singel D.J., and Stamler J.S. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364 (1993) 626-632
43. Martí J., Santa Cruz M.C., Bayer A.S., and Hervás J.P. The weaver gene expression affects neuronal generation patterns depending on the age and encephalic region. Neurosci. Lett. 396 3 (2006) 202-206
44. Martí J., Santa-Cruz M.C., Bayer S.A., Ghetti B., and Hervás J.P. Generation and survival of midbrain dopaminergic neurons in weaver mice. Int. J. Dev. Neurosci. 25 5 (2007) 299-307
45. Mehler-Wex C., Riederer P., and Gerlach M. Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder. Neurotox. Res. 10 3-4 (2006) 167-179
46. Morris B.J., Simpson C.S., Mundell S., MacEachern K., Johnston H.M., and Nolan A.M. Dynamic changes in NADPH-diaphorase staining reflect activity of nitric oxide synthase: evidence for a dopaminergic regulation of striatal nitric oxide release. Neuropharmacology 36 (1997) 1589-1599
47. Murata Y., and Masuko S. Developing patterns of nitric oxide synthesizing neurons in the rat striatum: histochemical analysis. Dev. Brain Res. 141 (2003) 91-99
48. Necchi D., Virgili M., Monti B., Contestabile A., and Scherini E. Regional alterations of the NO/NOS system in the aging brain: a biochemical, histochemical and immunochemical study in the rat. Brain Res. 933 1 (2002) 31-41
49. Olanow C.W. The pathogenesis of cell death in Parkinson's disease. Mov. Disord. 22 Suppl 17 (2007) S335-S342
50. Orieux G., François C., Féger J., Yelnik J., Vila M., Ruberg M., Agid Y., and Hirsch E.C. Metabolic activity of excitatory parafascicularis and pedunculopontine inputs to the subthalamic nucleus in a rat model of PD. Neuroscience 97 (2000) 79-88
51. Patil N., Cox D.R., Bhat D., Faham M., Myers R.M., and Peterson A.S. A potassium channel mutation in weaver mice implicates membrane excitability in granule cell differentiation. Nat. Genet. 11 (1995) 126-129
52. Patsoukis N., Papapostolou I., Zervoudakisa G., Georgiou C.D., Matsokisb N.A., Nikolaos T., and Panagopoulos. Thiol redox state and oxidative stress in midbrain and striatum of weaver mutant mice, a genetic model of nigrostriatal dopamine deficiency. Neurosci. Lett. 376 1 (2005) 24-28
53. Przedborski S., Jackson-Lewis V., Yokoyama R., Shibata T., Dawson V.L., and Dawson T.M. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc. Natl. Acad. Sci. U. S. A. 93 10 (1996) 4565-4571
54. Qureshi G.A., Baig S., Bednar I., Sodersten I., Forsberg G., and Siden A. Increased cerebrospinal fluid concentration of nitrite in PD. Neuroreport 6 (1995) 1642-1644
55. Rakic P., and Sidman R.L. organization of cerebellar cortex secondary to deficit of granule cells in weaver mutant mice. J. Comp. Neurol. 152 2 (1973) 133-161
56. Reader T.A., and Sénécal J. Distribution of glutamate receptors of the NMDA subtype in brains of heterozygous and homozygous weaver mutant mice. Neurochem. Res. 26 6 (2001) 579-589
57. Regidor J., Montesdeoca J., Ramirez-Gonzalez J.A., Hernandez-Urquia C.M., and Divac I. Bilateral induction of NADPH-diaphorase activity in neocortical and hippocampal neurons by unilateral injury. Brain Res. 631 (1993) 171-174
58. Rodrigo J., Springall D.R., Uttenthal O., Bentura M.L., Abadia-Molina F., Riveros-Moreno V., Martínez-Murillo R., Polak J.M., and Moncada S. Localization of nitric oxide synthase in the adult rat brain. Philos. Trans. R. Soc. Lond. B 345 (1994) 175-221
59. Rodriguez M.C., Obeso J.A., and Olanow C.W. Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: a target for neuroprotection. Ann. Neurol. 44 3 Suppl 1 (1998) S175-S188
60. Roffler-Tarlov S., and Graybiel A.M. Weaver mutation has differential effects on the DA-containing innervation of the limbic and nonlimbic striatum. Nature 307 (1984) 62-66
61. Roffler-Tarlov S., and Graybiel A.M. Expression of the weaver gene in dopamine-containing neural systems is dose-dependent and affects both striatal and nonstriatal regions. J. Neurosci. 6 11 (1986) 3319-3330
62. Roffler-Tarlov S., and Graybiel A.M. The postnatal development of the dopamine-containing innervation of dorsal and ventral striatum: effects of the weaver gene. J. Neurosci. 7 (1987) 2364-2372
63. Roffler-Tarlov S., Pugatch D., and Graybiel A.M. Patterns of cell and fiber vulnerability in the mesostriatal system of the mutant mouse weaver: II. High affinity uptake sites for dopamine. J. Neurosci. 10 (1990) 734-740
64. Roffler-Tarlov S., Martin B., Graybiel A.M., and Kauer J.S. Cell death in the midbrain of the murine mutation weaver. J. Neurosci. 16 (1996) 1819-1826
65. Sardo P., Carletti F., D'Agostino S., Rizzo V., and Ferraro G. Effects of nitric oxide-active drugs on the discharge of subthalamic neurons: microiontophoretic evidence in the rat. Eur. J. Neurosci. 24 7 (2006) 1995-2002
66. Schein J.C., Hunter D.D., and Roffler-Tarlov S. Girk2 expression in the ventral midbrain, cerebellum, and olfactory bulb and its relationship to the murine mutation weaver. Dev. Biol. 204 2 (1998) 432-450
67. Sekiguchi M., Nowakowski R.S., Nagato Y., Tanaka O., Guo H., Madoka M., and Abe H. Morphological abnormalities in the hippocampus of the weaver mutant mouse. Brain Res. 696 1-2 (1995) 262-267
68. Simonian S.H., and Herbison A.E. Localization of neuronal nitric oxide synthase-immunoreactivity within sub-populations of noradrenergic A1 and A2 neurons in the rat. Brain Res. 732 1-2 (1996) 247-252
69. Smeye R.J., and Goldowitz D. Purkinje cell loss is due to a direct action of the weaver gene in Purkinje cells: evidence from chimeric mice. Brain Res. Dev. Brain Res. 52 1-2 (1990) 211-218
70. Smith I.D., and Grace A.A. Role of the subthalamic nucleus in the regulation of nigral dopamine neuron activity. Synapse 12 4 (1992) 287-303
71. Smith D.E., and Shu-Guang X. Ultrastructural organization of GABA-like immunoreactive profiles in the weaver substantia nigra. J. Neurocytol. 32 (2003) 293-303
72. Smith Y., and Villalba R. Striatal and extrastriatal DA in the basal ganglia: an overview of its anatomical organization in normal and parkinsonian brains. Mov. Disord. 23 3 (2008) S534-S547
73. Smith D.E., Glover B., and Henry C. Dendritic changes in medium spiny neurons of the weaver striatum: a Golgi study. In: Graybiel A.M., Schmidt M.J., Sawyer B.D., Perry K.W., Fuller R.W., Foreman M.M., and Ghetti B. (Eds). The Basal Ganglia VI (2003)
74. Dopamine deficiency in the weaver mutant mouse. J. Neurosci. 2 (1982) 376-380
75. Stotz E.H., Palacios J.M., Landwehrmeyer B., Norton J., Ghetti B., Simon J.R., and Triarhou L.C. Alterations in dopamine and serotonin uptake systems in the striatum of the weaver mutant mouse. J. Neural Transm. Gen. Sect. 97 1 (1994) 51-64
76. Strazielle C., Lalonde R., Amdiss F., Botez M.J., Hébert C., and Reader T.A. Distribution of dopamine transporters in basal ganglia of cerebellar ataxic mice by [125I]RTI-121 quantitative autoradiography. Neurochem. Int. 32 (1998) 61-68
77. Strazielle C., Deiss V., Naudon L., Raisman-Vozari R., and Lalonde R. Regional brain variations of cytochrome oxidase activity and motor coordination in Girk2(Wv) (Weaver) mutant mice. Neuroscience 142 2 (2006) 437-449
78. Tong Y., Wei J., Zhang S., Strong J.A., Dlouhy S.R., Hodes M.E., Ghetti B., and Yu L. The weaver mutation changes the ion selectivity of the affected inwardly rectifying potassium channel GIRK2. FEBS Lett. 390 1 (1996) 63-68
79. Triarhou L.C., and Ghetti B. The dendritic dopamine projection of the substantia nigra: phenotypic denominator of weaver gene action in hetero- and homozygosity. Brain Res. 501 (1989) 373-381
80. Triarhou L.C., and Ghetti B. Serotonin-immunoreactivity in the cerebellum of two neurological mice and the corresponding control wild-type genetic stocks. J. Chem. Neuroanat. 4 6 (1991) 421-428
81. Triarhou L.C., Norton J., and Ghetti B. Mesencephalic dopamine cell deficit involves areas A8, A9 and A10 in weaver mutant mice. Exp. Brain Res. 70 (1988) 256-265
82. Vallance P., and Leiper J. Blocking NO synthesis: how, where and why?. Nat. Rev. Drug Discov. 1 (2002) 939-950
83. Verney C., Febvret-Muzerelle A., and Gaspar P. Early postnatal changes of the dopaminergic mesencephalic neurons in the weaver mutant mouse. Brain Res. Dev. Brain Res. 89 1 (1995) 115-119
84. Vila M., Levy R., Herrero M.T., Faucheux B., Obeso J.A., Agid Y., and Hirsch E.C. Metabolic activity of the basal ganglia in Parkinsonian syndromes in human and non-human-primates: a cytochrome oxidase histochemistry study. Neuroscience 71 (1996) 903-912
85. Villar M.J., Ceccatelli S., Ronnqvist M., and Hokfelt T. Nitric oxide synthase increases in hypothalamic magnocellular neurons after salt loading in the rat. An immunohistochemical and in situ hybridization study. Brain Res. 644 2 (1994) 273-281
86. Vincent S.R. Nitric oxide: a radical neurotransmitter in the central nervous system. Prog. Neurobiol. 42 1 (1994) 129-160
87. Vincent S.R., and Kimura H. Histochemical mapping of nitric-oxide synthase in the rat brain. Neuroscience 46 (1992) 755-784
88. Vogelweid C.M., Verina T., Norton J., Harruff R., and Ghetti B. Hypospermatogenesis is the cause of infertility in the male weaver mutant mouse. J. Neurogenet. 9 2 (1993) 89-104
89. Wu W. Expression of nitric-oxide synthase (NOS) in injured CNS neurons as shown by NADPH diaphorase histochemistry. Exp. Neurol. 120 (1993) 153-159
90. Wu H.H., Williams C.V., and Mcloon S.C. Involvement of nitric oxide in the elimination of a transient retinotectal projection in development. Science 265 (1994) 1593-1596